TCL Archive ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies May 2, 2003
TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012